FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Gly topics
Door Assembly
Swimming Goggles
Transverse
Alkoxylate
Fluoropolymer
Air Cleaning
Rotor Shaft
Aspect Ratio
Disconnect
Synchronization
Remote Control
Ethylene Glycol
Surfactant
Combustion
Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Gly patents



      
           
This page is updated frequently with new Gly-related patents. Subscribe to the Gly RSS feed to automatically get the update: related Gly RSS feeds.

Subscribe to updates on this page: Gly RSS RSS

Date/App# patent app List of recent Gly-related patents
04/17/14
20140109256
 Glyphosate-tolerant wheat genotypes patent thumbnailnew patent Glyphosate-tolerant wheat genotypes
The present invention provides methods for producing glyphosate-tolerant wheat genotypes by mutagenesis, glyphosate wheat plants produced by such methods, and related compositions and methods.. .
04/17/14
20140108281
 Method and system for social network analysis patent thumbnailnew patent Method and system for social network analysis
Methods and system for social commerce network analysis are described. In one embodiment, a strongly connected component value, an in-component value, an out-component value, a disconnected component value, a tendril value, and a tube value of a social network for a time period may be accessed.
04/17/14
20140107380
 Method for producing bioderived dipropylene and tripropylene glycols without propylene oxide patent thumbnailnew patent Method for producing bioderived dipropylene and tripropylene glycols without propylene oxide
A method is provided for producing bioderived dipropylene and tripropylene glycols without using propylene oxide. The method utilizes a bioderived (mono)propylene glycol as a feed, and in one embodiment performs an acid-catalyzed condensation process to convert the bioderived propylene glycol to products including at least dipropylene glycol and preferably including tripropylene glycol as well.
04/17/14
20140107360
 Lipid-lowering antidiabetic agent patent thumbnailnew patent Lipid-lowering antidiabetic agent
A composition which includes a salt of metformin and the use of the composition for treatment of or use in prediabetes, diabetes, lowering triglycerides and/or other conditions in mammals.. .
04/17/14
20140107349
 Methods for preparing polymeric reagents patent thumbnailnew patent Methods for preparing polymeric reagents
The present invention provides among other things methods for preparing polymeric reagents, wherein the method comprises (a) providing an aromatic moiety bearing a hydroxy group, a first amino group and a second amino group; (b) reacting a functional group reagent with the hydroxy group to result in a hydroxy group bearing a functional group capable of reacting with an amino group of an active agent and resulting in a hydrolyzable carbamate; and (c) reacting a plurality of poly(alkylene glycol) water-soluble polymers bearing a reactive group with the first amino group and second amino group to result in (i) a first amino group bearing a water-soluble polymer through a spacer moiety, and (ii) a second amino group bearing a second water-soluble polymer through a spacer moiety.. .
04/17/14
20140107311
 Thermoplastic polyurethane with reduced tendency to bloom from a bio-based glycol patent thumbnailnew patent Thermoplastic polyurethane with reduced tendency to bloom from a bio-based glycol
The present invention discloses a thermoplastic polyurethane comprised of the reaction product of (1) a hydroxyl terminated polyester intermediate, (2) a polyisocyanate, and (3) a glycol chain extender; wherein the polyester intermediate is comprised of repeat units derived from a 1,3-propylene glycol component and a dicarboxylic acid wherein the 1,3-propylene glycol component comprises a bio-based 1,3-propylene glycol; wherein the polyester intermediate has a number average molecular weight from 500 to 10,000; and wherein the polyurethane includes hard segments that are the reaction product of the polyisocyanate and the glycol chain extender. This thermoplastic polyurethane is unique as it has a greatly reduced tendency to bloom and is prepared from a renewable material.
04/17/14
20140107246
 Ultraviolet cured polyesters from sustainable materials patent thumbnailnew patent Ultraviolet cured polyesters from sustainable materials
Crosslinked, ultraviolet cured polycondensation products of either a saturated or unsaturated polyol and an unsaturated polyacid are disclosed. The preferred monomers used in the present invention are sustainable monomers, such as glycerol, castor oil, fumaric acid, sebacic acid, and citric acid.
04/17/14
20140107229
 Oil-in-water emulsions patent thumbnailnew patent Oil-in-water emulsions
The invention relates to oil-in-water emulsions based on fatty alcohols and mono- or diesters of glycerol and the use thereof as antifoams or deaerators for aqueous compositions. The oil phase of the emulsions according to the invention consists to at least 95% by weight of the following constituents: a) 40 to 95% by weight, based on the total weight of the oil phase, of a mixture of at least two alcohols as component a, consisting of: a1) at least one alkanol having 12 to 30 carbon atoms as component a1, a2) at least one mono- or diester of glycerol with at least one fatty acid having 14 to 24 carbon atoms as component a2; b) 0.1 to 10% by weight, based on the total weight of the oil phase, of at least one further component b, which is selected from esters of c12-c36-alkanecarboxylic acids with polyglycerol, amides of c12-c36-alkanecarboxylic acids with alkylenediamines or oligoalkyleneamines, and esters of c12-c36-alkanecarboxylic acids with c12-c36-alkanols, and mixtures thereof, c) 4.9 to 50% by weight, based on the total weight of the oil phase, of at least one further component c, which is selected from organic substances which are liquid at 50° c.
04/17/14
20140107194
 Compounds for use in the treatment of immune related inflammatory disease patent thumbnailnew patent Compounds for use in the treatment of immune related inflammatory disease
Compounds particularly for use in an autoimmune inflammatory disease and especially the treatment of inflammatory bowel disease have the formula: wherein r is selected from one or more of the same or different of hydrogen, hydroxyl, optionally substituted alkyl, optionally substituted aryl, alkoxy, aryloxy, thiol, and optionally substituted amino, and wherein r1 is selected from one or more of the same or different of hydrogen, acetyl, optionally substituted alkyl, optionally substituted aryl, and an amino acid selected from leucine, valine, isoleucine, and glycine.. .
04/17/14
20140107145
 Compositions for drug administration patent thumbnailnew patent Compositions for drug administration
The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms..
04/17/14
20140107074
new patent Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
Y is selected from the group consisting of a bond, optionally substituted c1-6 alkylene, optionally substituted benzene, pyridinyl, a polyethylene glycol linker and —(ch2)1-6o(ch2)1-6—, and methods of using such compounds for the treatment of irritable bowel syndrome, chronic kidney disease and end-stage renal disease.. .
04/17/14
20140107068
new patent Marker for determination of sensitivity to anticancer agent
A marker can determine whether or not a patient has a therapeutic response to an anti-cancer agent. A novel cancer therapy employs the marker.
04/17/14
20140107064
new patent Glycosaminoglycan oral use and compositions
The present invention concerns the use of a glycosaminoglycan association of hyaluronic acid and chondroitin sulfate for the preparation of oral compositions for the prevention or for the treatment of upper gastro-intestinal tract disorders and for the preparation of upper gastro-intestinal epithelial damage, as well as the oral compositions comprising said glycosaminoglycan association.. .
04/17/14
20140107052
new patent Edible composition
Foods or meals high in available carbohydrate such as sucrose or starch increase postprandial blood glucose concentrations. Repeated high post-prandial plasma glucose “spikes” are associated with an increased risk of developing type ii diabetes.
04/17/14
20140107037
new patent Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders
The disclosure relates, at least in part, to methods of treating autism in a patient in need thereof by administering an effective amount of a disclosed compound, e.g., a nmda receptor glycine site partial agonist.. .
04/17/14
20140107004
new patent Natural and synthetic ester-containing lubricants having enhanced hydrolytic stability
A lubricant composition comprising (a) from 0.1 to 10 percent by weight of one or more polyalkylene glycols (pag); and (2) one or more ester base oils selected from the group of natural esters, synthetic esters and combinations thereof; wherein the one or more pag has a molecular weight in the range 1500 to 5000 g/mole, comprises from 10 to 40 percent by weight of units derived from ethylene oxide and from 90 to 60 percent by weight of units derived from propylene oxide; and wherein the one or more pags are in the form of block copolymer, reverse block copolymer or combinations thereof is provided. Also provided is a method of enhancing the hydrolytic stability of an ester base oil..
04/17/14
20140106993
new patent Systems and methods for processing glycerol
Systems and methods for processing glycerol into one or more products and uses thereof are provided. In one or more embodiments, a method for treating soil can include applying a partially oxidized reaction product to a soil.
04/17/14
20140106417
new patent Dgat genes and methods of use for triglyceride production in recombinant microorganisms
The present invention provides novel diacylglycerol acyltransferase (dgat) genes, including novel genes encoding localization peptides. The present invention also provides recombinant cells, such as algae, transformed with dgat genes and methods of using such recombinant cells to produce triglyceride..
04/17/14
20140106371
new patent Peptide analogues of pa-il and their utility for glycan and glycoconjugate analysis and purification
Also included are methods for detecting changes in the glycosylation of carbohydrates and for separating biomolecules which contain glycoproteins or glycoconjugates.. .
04/17/14
20140106015
new patent Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications
The present invention relates to a composition for the prevention and treatment of diabetes mellitus and diabetic complications. The composition includes as an active ingredient, a heat-treated powder or extract of glycine soja with hypoglycemic effects.
04/17/14
20140106008
new patent Glycerol compositions and solutions
The invention discloses the use of a treatment composition for preventing, or reducing, the production of contaminants selected from microorganisms and microorganism-produced toxins by contacting the substrate with the composition. The composition comprises a water glycerol mixture and calcium hydroxide in which the percentage by mass of glycerol in the water glycerol mixture is between 5% and 95%, at least some of the calcium hydroxide is dissolved in the water glycerol mixture and the concentration of the dissolved calcium hydroxide in the water glycerol mixture is at least 1.5 times higher than the maximum concentration of dissolved calcium hydroxide which can be obtained in water alone, thereby preventing or reducing the production of the contaminants.
04/17/14
20140105931
new patent Hepatitis c virus particles, vaccines, compositions and methods related thereto
This disclosure relates to viral particles and nucleic acids encoding an hcv envelope glycoprotein 2 containing a mutation. Viral particles can be created and administered to a subject to illicit an immune response..
04/17/14
20140105911
new patent Method of treatment of vascular complications
The present invention provides methods for the prevention or treatment of one or more vascular complication(s) in a subject at risk of developing diabetes mellitus, impaired glucose tolerance and/or hyperglycemia or a subject suffering from diabetes mellitus, impaired glucose tolerance and/or hyperglycemia, wherein an amount of a composition effective to inhibit, repress, delay or otherwise reduce expression and/or activity and/or level of txnip and/or an amount of a composition effective to induce, enhance or otherwise increase expression and/or activity and/or level of trx is/are administered to a subject in need thereof. The present invention also provides methods for identifying and isolating modulators of txnip expression and/or activity and/or level and/or trx expression and/or activity and/or level for use in such therapeutic and prophylactic methods..
04/17/14
20140105879
new patent Flour-based functional food
The invention relates to a functional flour-based food composition, in particular baked products, and a method for the preparation thereof. Specific substances of vegetable origin principally containing policosanols, isoflavones and vegetable statins are added to the flour, or to the dough for preparing the aforesaid baked products.
04/17/14
20140105844
new patent Human sebum mimetics derived from botanical sources and methods for making the same
Human sebum mimetics and methods for producing human sebum mimetics are provided. In one exemplary embodiment, a human sebum mimetic comprises a wax ester derived from interesterification of a refined botanical triglyceride oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, phytosqualene, and phytosteryl macadamiate.
04/17/14
20140105839
new patent Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
The present invention relates to a compound of the following formula (i): as well as its process of preparation, pharmaceutical and cosmetics composition comprising it and use thereof, notably as an inhibitor of the sodium-dependent glucose co-transporter, such as sglt1, sglt2 and sglt3, in particular in the treatment or prevention of diabetes, and more particularly type-ii diabetes, diabetes-related complications, such as arthritis of the lower extremities, cardiac infarction, renal insufficiency, neuropathy or blindness, hyperglycemia, hyperinsulinemia, obesity, hypertriglyceridemia, x syndrome and arteriosclerosis, as well as for its use as an anticancer, anti-infective, anti-viral, anti-thrombotic or anti-inflammatory drug, or for lightening, bleaching, depigmenting the skin, removing blemishes from the skin, particularly age spots and freckles, or preventing pigmentation of the skin.. .
04/17/14
20140105836
new patent Lipstick and other cosmetics and method of making
Inventive subject matter disclosed herein relates to a lipstick. The lipstick includes a colorant paste comprising one or more dry pigments and fractionated coconut oil; a coconut gel comprising vegetable oil, cocos nucifera oil, a styrene/butadiene copolymer and polyethylene; and polyethylene, caprylyl glycol, and a mixture of acacia decurrens/jojoba/sunflower seed wax/polyglyceryl 3-ester in concentrations effective for ensuring coconut gel and fractionated coconut oil are melted and homogeneous..
04/17/14
20140104751
new patent Nanobiomimetic supercapacitors with high rate high energy storage
Nanobiomimetic supercapacitors comprise an “electron well” and an “electron-dam” membrane electrode assembling (mea); the “electron-well” mea compromises an electrode comprising a substrate of glassy carbon; a self-assembling membrane comprises a polymer matrix; wherein the polymer matrix is comprised of an electrically conductive copolymer; wherein the copolymer is further comprised of one or more first β-cyclodextrin molecules having at least one or more free acetyl groups; one or more polyethylene glycol molecules; one or more poly(4-vinylpyridine) molecules; and one or more second β-cyclodextrin molecules; the self-assembling membrane having a surface structure comprising one or more nanopores and pillars; the nanopores and pillars are vertically oriented on the substrate to form nanopore and pillar array; the “electron-dam” mea compromises the nanopore/pillar layer sealed with an embedded hydrophobic aromatic substance having a flat lid structure; wherein the mea can be as either said positive or negative electrode; wherein the “electron-well” also can be either said as positive or negative electrode; separated by a porous insulator wetted by an electrolyte-free and air-independent organic solution; at least two current collectors are at each of the end of the meas.. .
04/17/14
20140102486
new patent Cleaning agent for removal of contaminates from manufactured products
A composition effective for removing contaminates from a manufactured product either as a concentrated material or when diluted with water. The composition designed for effective removal of all types of undesirable contaminates from a manufactured product, including but not limited to, solder flux, oils, greases, soil, and particulate matter.
04/17/14
20140101988
new patent Fuels and fuel additives production from glycerol conversion using a monohydric alcohol and heterogeneous catalysis
The present disclosure relates to a method of converting glycerol into organic reaction products. The method may include mixing glycerol with a monohydric alcohol.
04/10/14
20140100331
Polyalkylene glycol block copolymers containing phosphorus groups and use thereof as emulsifiers for emulsion polymerization
N is a number from 3 to 100.. .
04/10/14
20140100318
Polylactic acid-polyalkylene glycol copolymer with fast crystallization rate and composition comprising the same
The provided are a polylactic acid-polyalkylene glycol copolymer and a composition comprising the same which have excellent crystallization rate, wherein the polylactic acid-polyalkylene glycol copolymer is prepared by melt-reacting polylactic acid with polyalkylene glycol of which one end group is substituted with a functional group and has improved eco-friendliness, injection moldability, and excellent heat resistance which makes it to be suitably applied to various molded articles requiring great heat resistance, such as disposables, kitchen utensils and containers, electric-electronic parts and automobile parts.. .
04/10/14
20140100279
Extracts from eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
The present invention relates to the discovery that compounds isolated from the leaves of the plant eucalyptus camaldulensis can be used to treat or prevent hyperglycemia and/or hypertension.. .
04/10/14
20140100275
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100274
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100273
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100272
Methods of administering compositions comprising docosapentaenoic acid
The present invention relates to compositions comprising docosapentaenoic acid and methods of reducing lipid parameters, such as triglycerides, total cholesterol, low density lipoprotein (ldl) cholesterol, non-hdl cholesterol, free fatty acids, and other lipids, comprising administration of omega-3 docosapentaenoic acid.. .
04/10/14
20140100267
Functional food additives
Novel compounds, and in particular to diacylglycerol (1, 3-dag) and alpha-lipoic acid (la) and/or dihydro-alpha-lipoic acid (dhla) derivatives. In particular these novel compounds are used as functional food additives.
04/10/14
20140100196
Phytosanitary microemulsion and the procedure for obtaining it
A phytosanitary microemulsion and procedure for obtaining it, wherein the resulting microemulsion is highly stable, with low content of surfactants, achieved due to a combination of an active ingredient, preferably cypermethrin, chlorpirifos or mixtures thereof; refined soy oil; a surfactant at a very low content due to the inclusion of soy oil; a biocide; bidistilled glycerine; xanthan gum and water until reaching the volume.. .
04/10/14
20140100190
Use of lipid conjugates in cystic fibrosis and applications thereof
Wherein l is a lipid or a phospholipid, z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, y is either nothing or a spacer group ranging in length from 2 to 30 atoms, x is a physiologically acceptable monomer, dimer, oligomer, or polymer, wherein x is a glycosaminoglycan; and n is a number from 1 to 1000, wherein any bond between l, z, y and x is either an amide or an esteric bond in treating a subject suffering from cystic fibrosis, reducing or delaying the mortality of a subject suffering from cystic fibrosis or ameliorating symptoms associated with cystic fibrosis.. .
04/10/14
20140100177
Composition comprising cashew apple extract
The invention concerns a cashew apple extract and a composition comprising a cashew apple extract and optionally a carrier, in particular for use for allowing reduction of body weight gain or limitation of increasing body weight, reduction or limitation of fat storage, of fatty liver, of liver triglycerides level, of hypertriglyceridemia, of glycemia level, of insulinemia, of insulin resistance, and/or of one or several factors of metabolic syndrome.. .
04/10/14
20140100158
Use of ultrarapid acting insulin
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.. .
04/10/14
20140100157
Method of inhibiting clostridium difficile by administration of oritavancin
Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of c. Difficile and c.
04/10/14
20140099871
Self-contained fibrous buffing article
A self-contained fibrous buffing article including at least one layer of a fibrous nonwoven fabric; the nonwoven fabric having a hardened adherent coating including a crosslinked binder, abrasive particles, and a lubricant blend; and the lubricant blend including at least a fatty acid, mineral oil and glycerin.. .
04/10/14
20140099725
Methods for the analysis of glycoproteins or glycopeptides by mass spectrometry
A method for the analysis of samples including one or more glycopeptides including the steps of separating one or more glycopeptides using a chromatography system to produce a chromatographic eluent, adding a supercharging reagent to the chromatographic eluent, providing the chromatographic eluent and supercharging reagent to a mass spectrometer, ionizing said chromatographic eluent and supercharging reagent in an ion source to produce glycopeptide ions, performing at least one ion ion reaction on at least some of the glycopeptide ions to produce fragment ions, mass analyzing the fragment ions to produce ion ion reaction mass spectral data, and interpreting the ion ion reaction data mass spectral data to provide structural information relating to the glycopeptide.. .
04/10/14
20140099701
Formulation and process for biocatalytic co2 capture using absorption compounds such as dimethylmonoethanolamine, diethylmonoethanolamine or dimethylglycine
A formulation and process for capturing co2 use an absorption mixture containing water, biocatalysts and an absorption compound selected from dimethylmonoethanolamine (dmmea), diethylmonoethanolamine (demea), and dimethylglycine. The process may include contacting a co2-containing gas with the absorption mixture to enable dissolution and transformation of co2 into bicarbonate and hydrogen ions, thereby producing a co2-depleted gas and an ion-rich solution, followed by subjecting the ion-rich solution to desorption..
04/10/14
20140099638
Brassica gat event and compositions and methods for the identification and/or detection thereof
Compositions and methods related to transgenic glyphosate tolerant brassica plants are provided. Specifically, the present invention provides brassica plants having a dp-073496-4 event which imparts tolerance to glyphosate.
04/10/14
20140099629
Platelet additive solution having a beta-galactosidase inhibitor
The present invention relates to a platelet additive solution (pas) having an amount of one or more β-galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of pas components that include a salt, a citrate source, a carbon source, or any combination thereof.. .
04/10/14
20140099403
Methods for purifying steviol glycosides and uses of the same
Methods for purifying steviol glycosides, including rebaudioside x, are provided herein. Sweetener and sweetened containing rebaudioside x are also provided herein.
04/10/14
20140099345
Omega-3 diglyceride emulsions
The present invention relates to omega-3 diglyceride emulsions characterized in that the lipid phase comprises at least about 40 wt.-% of diglycerides. Preferably about 70 wt.-% of the acyl-groups of said diglycerides are eicoapentaenoic acid (epa) groups and/or docasahexaenoic (dha) groups.
04/10/14
20140099344
Process for dispersing amino acids
A coated proteinaceous material can be produced by contacting the proteinaceous material with de-oiled phospholipids or mixtures thereof containing less than 20% triglycerides. The coating has between 0.1 and 1.5% by weight of the total proteinaceous material, of de-oiled lecithin.
04/10/14
20140099338
Yeast expressed classical swine fever virus glycoprotein e2 and use thereof
The present invention provides a recombinant yeast system for expressing the glycoprotein e2 of classical swine fever virus (csfv), in which the expression level of ye2 is improved by codon optimization and shortening coding region of e2 gene. The truncated e2 subunits are used as major active ingredient in anti-csfv vaccines and useful diagnostic blocking elisa kits for csfv infection with easy manipulation and low cost..
04/10/14
20140099278
Biocompatible polycaprolactone fumarate formulations
A polycaprolactone fumarate polymer useful as a matrix material for a biocompatible scaffold for tissue engineering applications is disclosed. The polycaprolactone fumarate polymer can be prepared by reacting caprolactone with an alkane polyol to prepare a polycaprolactone precursor, and then reacting the polycaprolactone precursor with fumaric acid or a salt thereof to prepare the polycaprolactone fumarate polymer.
04/10/14
20140099269
Chewing gum having sustained release of nicotine
The present invention relates to a chewing gum having a high surface area to volume ratio (sav ratio), wherein said chewing gum comprises a water insoluble gum base matrix, a water soluble bulk portion and nicotine, wherein the gum base matrix, nicotine and the bulk portion are mixed and extruded to form a final extruded chewing gum product having a sav ratio above 0.7, and wherein sustained release of nicotine is facilitated by adding 0.1-10% of c8-c10 triglycerides by weight of the chewing gum.. .


Popular terms: [SEARCH]

Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4102

3568

4 - 0 - 86